rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Ajay Patel

EVP and CFO

Company insider

Files Form 4 as: EVP and CFO, Assertio Holdings.

Every Form 4 they filed

In numbers

Trades disclosed
90
Buys
1
Sells
1
Bought
$13K
Sold
$196K
Companies
1
Companies where not an officer
0
First trade
20 May 2021
Last trade
16 Jun 2026
Last filed
16 Jun 2026

Companies traded

Where they are an officer
Assertio HoldingsOfficer · Biotechnology · last 16 Jun 20261 buy · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Jun 2026filed 16 Jun 2026Assertio HoldingsBiotechnologySEC FORM 4 Code U—15,942 at $0.00filing
16 Jun 2026filed 16 Jun 2026Assertio Holdingsoption or derivative · BiotechnologySEC FORM 4 Code D—26,026 at $0.00filing
16 Jun 2026filed 16 Jun 2026Assertio Holdingsoption or derivative · BiotechnologySEC FORM 4 Code D—15,666filing
16 Jun 2026filed 16 Jun 2026Assertio Holdingsoption or derivativeSEC FORM 4 Code D—26,026 at $0.00filing
16 Jun 2026filed 16 Jun 2026Assertio Holdingsoption or derivativeSEC FORM 4 Code D—15,666filing
16 Jun 2026filed 16 Jun 2026Assertio Holdingsoption or derivativeSEC FORM 4 Code D—22,666filing
16 Jun 2026filed 16 Jun 2026Assertio Holdingsoption or derivativeSEC FORM 4 Code D—12,591filing
16 Jun 2026filed 16 Jun 2026Assertio Holdingsoption or derivativeSEC FORM 4 Code D—21,128filing
16 Jun 2026filed 16 Jun 2026Assertio Holdingsoption or derivative · BiotechnologySEC FORM 4 Code D—22,666filing
16 Jun 2026filed 16 Jun 2026Assertio Holdingsoption or derivative · BiotechnologySEC FORM 4 Code D—12,591filing
16 Jun 2026filed 16 Jun 2026Assertio Holdingsoption or derivative · BiotechnologySEC FORM 4 Code D—21,128filing
16 Jun 2026filed 16 Jun 2026Assertio HoldingsSEC FORM 4 Code U—15,942 at $0.00filing
2 Mar 2026filed 3 Mar 2026Assertio Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—18,804 at $0.00filing
2 Mar 2026filed 3 Mar 2026Assertio Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—21,128 at $0.00filing
2 Mar 2026filed 3 Mar 2026Assertio Holdingsoption or derivativeSEC FORM 4 Code A—18,804 at $0.00filing
2 Mar 2026filed 3 Mar 2026Assertio Holdingsoption or derivativeSEC FORM 4 Code A—21,128 at $0.00filing
21 Feb 2026filed 24 Feb 2026Assertio HoldingsBiotechnologySEC FORM 4 Code M—1,143 at $0.00filing
21 Feb 2026filed 24 Feb 2026Assertio HoldingsBiotechnologySEC FORM 4 Code F$6,701566 at $11.84filing
21 Feb 2026filed 24 Feb 2026Assertio Holdingsoption or derivative · BiotechnologySEC FORM 4 Code M—1,143 at $0.00filing
21 Feb 2026filed 24 Feb 2026Assertio Holdingsoption or derivativeSEC FORM 4 Code M—1,143 at $0.00filing

Sectors

Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

William McKeeDirector · Director at Assertio Holdings, filing Form 4 there in the last year
Mark L. ReisenauerCEO · CEO at Assertio Holdings, filing Form 4 there in the last year
Sigurd KirkDirector · Director at Assertio Holdings, filing Form 4 there in the last year
Heather L. MasonDirector · Director at Assertio Holdings, filing Form 4 there in the last year
David Matthew StarkDirector · Director at Assertio Holdings, filing Form 4 there in the last year